+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Critical issues with the in vivo comet assay: A report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT)



Critical issues with the in vivo comet assay: A report of the comet assay working group in the 6th International Workshop on Genotoxicity Testing (IWGT)



Mutation Research. Genetic Toxicology and Environmental Mutagenesis 783: 6



As a part of the 6th IWGT, an expert working group on the comet assay evaluated critical topics related to the use of the in vivo comet assay in regulatory genotoxicity testing. The areas covered were: identification of the domain of applicability and regulatory acceptance, identification of critical parameters of the protocol and attempts to standardize the assay, experience with combination and integration with other in vivo studies, demonstration of laboratory proficiency, sensitivity and power of the protocol used, use of different tissues, freezing of samples, and choice of appropriate measures of cytotoxicity. The standard protocol detects various types of DNA lesions but it does not detect all types of DNA damage. Modifications of the standard protocol may be used to detect additional types of specific DNA damage (e.g., cross-links, bulky adducts, oxidized bases). In addition, the working group identified critical parameters that should be carefully controlled and described in detail in every published study protocol. In vivo comet assay results are more reliable if they were obtained in laboratories that have demonstrated proficiency. This includes demonstration of adequate response to vehicle controls and an adequate response to a positive control for each tissue being examined. There was a general agreement that freezing of samples is an option but more data are needed in order to establish generally accepted protocols. With regard to tissue toxicity, the working group concluded that cytotoxicity could be a confounder of comet results. It is recommended to look at multiple parameters such as histopathological observations, organ-specific clinical chemistry as well as indicators of tissue inflammation to decide whether compound-specific toxicity might influence the result. The expert working group concluded that the alkaline in vivo comet assay is a mature test for the evaluation of genotoxicity and can be recommended to regulatory agencies for use.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057534572

Download citation: RISBibTeXText

PMID: 25953395

DOI: 10.1016/j.mrgentox.2014.09.006


Related references

The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup. Mutation Research. Genetic Toxicology and Environmental Mutagenesis 783: 23-35, 2015

Launch of the ComNet (comet network) project on the comet assay in human population studies during the International Comet Assay Workshop meeting in Kusadasi, Turkey (September 13-16, 2011). Mutagenesis 27(4): 385-386, 2012

The next three decades of the comet assay: a report of the 11th International Comet Assay Workshop. Mutagenesis 32(3): 397-408, 2017

Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutation Research 627(1): 31-35, 2007

The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis 20(4): 245-254, 2005

Evaluation of 4,4'-diaminodiphenyl ether in the rat comet assay: Part of the Japanese Center for the Validation of Alternative Methods (JaCVAM)-initiative international validation study of in vivo rat alkaline comet assay. Mutation Research. Genetic Toxicology and Environmental Mutagenesis 786-788: 125-128, 2015

Critical factors to be considered when testing nanomaterials for genotoxicity with the comet assay. Mutagenesis 30(1): 85-88, 2015

Evaluation of p-phenylenediamine, o-phenylphenol sodium salt, and 2,4-diaminotoluene in the rat comet assay as part of the Japanese Center for the Validation of Alternative Methods (JaCVAM)-initiated international validation study of in vivo rat alkaline comet assay. Mutation Research. Genetic Toxicology and Environmental Mutagenesis 786-788: 151-157, 2015

Assessment and reduction of comet assay variation in relation to DNA damage: studies from the European Comet Assay Validation Group. Mutagenesis 25(2): 109-111, 2010

DNA-repair measurements by use of the modified comet assay: an inter-laboratory comparison within the European Comet Assay Validation Group (ECVAG). Mutation Research 757(1): 60-67, 2013

Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by the comet assay and the cytokinesis-block micronucleus assay. Mutation Research 748(1-2): 42-47, 2012

Genotoxicity testing of PLGA-PEO nanoparticles in TK6 cells by means of the comet assay and the cytokinesis-block micronucleus assay. 2012

In vivo genotoxicity assessment of sertraline by using alkaline comet assay and the cytokinesis-block micronucleus assay. Basic and Clinical Pharmacology and Toxicology 113(5): 339-346, 2013

The in vitro and in vivo genotoxicity of isotretinoin assessed by cytokinesis blocked micronucleus assay and comet assay. Toxicology in Vitro 27(2): 900-907, 2013

Recent advances in in vivo genotoxicity testing: prediction of carcinogenic potential using comet and micronucleus assay in animal models. Journal of Cancer Prevention 18(4): 277-288, 2013